Serum lipoprotein levels in takotsubo cardiomyopathy vs. myocardial infarction

International Archives of Medicine

Volumn 4, Issue 1, 2011, Pages

  Gaddam, Sainath ^a   Nimmagadda, Krishna C ^b   Nagrani, Tarun ^a   Naqi, Muniba ^a   Wetz, Robert V ^a   Weiserbs, Kera F ^a   McCord, Donald ^a   Ghavami, Foad ^a   Gala, Bhavesh ^a   Lafferty, James C ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; FEMALE; HEART INFARCTION; HUMAN; LIPID ANALYSIS; MALE; RETROSPECTIVE STUDY; TAKOTSUBO CARDIOMYOPATHY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79955165490     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-4-14     Document Type: Article

References (17)

1. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. YJ Akashi DS Goldstein G Barbaro T Ueyama, Circulation 2008 118 25 2754 62 10.1161/CIRCULATIONAHA.108.767012 19106400
2. Neurohumoral features of myocardial stunning due to sudden emotional stress. IS Wittstein DR Thiemann JA Lima KL Baughman SP Schulman G Gerstenblith KC Wu JJ Rade TJ Bivalacqua HC Champion, N Engl J Med 2005 352 6 539 48 10.1056/NEJMoa043046 15703419 (Pubitemid 40204667)
3. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction: Angina Pectoris-Myocardial Infarction Investigations in Japan. K Tsuchihashi K Ueshima T Uchida N Oh-Mura K Kimura M Owa M Yoshiyama S Miyazaki K Haze H Ogawa T Honda M Hase R Kai I Morii, J Am Coll Cardiol 2001 38 11 18 10.1016/S0735-1097(01) 01316-X 11451258 (Pubitemid 32613822)
4. Chronic pharmacological treatment in takotsubo cardiomyopathy. G Fazio C Pizzuto G Barbaro L Sutera E Incalcaterra G Evola S Azzarelli T Palecek G Di Gesaro C Cascio G Novo YJ Akashi S Novo, Int J Cardiol 2008 127 1 121 3 10.1016/j.ijcard.2007.04.013 17544159 (Pubitemid 351707512)
5. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial. SA Murphy CP Cannon SD Wiviott CH McCabe E Braunwald, J Am Coll Cardiol 2009 54 25 2358 62 10.1016/j.jacc.2009.10.005 20082923
6. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Circulation 2002 106 25 3143 421 12485966
7. A to Z Investigators. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JA de Lemos MA Blazing SD Wiviott EF Lewis KA Fox HD White JL Rouleau TR Pedersen LH Gardner R Mukherjee KE Ramsey J Palmisano DW Bilheimer MA Pfeffer RM Califf E Braunwald, JAMA 2004 292 11 1307 16 10.1001/jama.292.11. 1307 15337732 (Pubitemid 39223221)
8. Low fasting serum triglyceride level as a precocious marker of autoimmune disorders. S Iannello A Cavaleri P Milazzo S Cantarella F Belfiore, MedGenMed 2003 5 3 20 14745367
9. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. T Gordon WP Castelli MC Hjortland WB Kannel TR Dawber, Am J Med 1977 62 5 707 14 10.1016/0002-9343(77)90874-9 193398 (Pubitemid 8110784)
10. Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome. KA Bybee J Murphy A Prasad RS Wright A Lerman CS Rihal P Chareonthaitawee, J Nucl Cardiol 2006 13 2 244 50 PubMed PMID: 16580961. 16580961
11. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. S Kurisu I Inoue T Kawagoe M Ishihara Y Shimatani K Nishioka T Umemura S Nakamura M Yoshida H Sato, J Am Coll Cardiol 2003 41 5 743 8 10.1016/S0735-1097(02)02924-8 12628716 (Pubitemid 36308379)
12. Different pattern of regional metabolic abnormalities in Takotsubo cardiomyopathy as evidenced by F-18 FDG PET-CT. G Rendl L Rettenbacher P Keinrath J Altenberger J Schuler M Heigert M Pichler C Pirich, Wien Klin Wochenschr 2010 122 5-6 184 5 10.1007/s00508-010-1356-7 20361383
13. Repeated serum lipid measurements during the peri-hospitalization period. H Nawaz BP Comerford VY Njike AJ Dhond M Plavec DL Katz, Am J Cardiol 2006 98 10 1379 82 Epub 2006 Sep 28. 10.1016/j.amjcard.2006.06.030 17134633 (Pubitemid 44666644)
14. How soon after myocardial infarction should plasma lipid values be assessed? RE Ryder TM Hayes IP Mulligan JC Kingswood S Williams DR Owens, Br Med J (Clin Res Ed) 1984 289 6459 1651 3 10.1136/bmj.289.6459.1651 (Pubitemid 15221971)
15. Serum lipids four weeks after acute myocardial infarction are a valid basis for lipid lowering intervention in patients receiving thrombolysis. R Carlsson G Lindberg L Westin B Israelsson, Br Heart J 1995 74 1 18 20 10.1136/hrt.74.1.18 7662447
16. Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction. D Heldenberg A Rubinstein O Levtov L Berns B Werbin I Tamir, Atherosclerosis 1980 35 4 433 7 10.1016/0021-9150(80)90184-7 7378123 (Pubitemid 10131095)
17. Plasma lipids can be reliably assessed within 24 hours after acute myocardial infarction. M Sewdarsen S Vythilingum I Jialal R Nadar, Postgrad Med J 1988 64 751 352 6 10.1136/pgmj.64.751.352 3200776